Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coconut shell activated carbon (CSAC) is a porous material derived from coconut shells, primarily utilized for its adsorptive properties. It is employed in various applications such as the removal of bis(2-ethylhexyl) phosphate (P204) and 6:2 Chlorinated polyfluoroalkyl ether acid (F-53B) from water, the adsorption of gaseous aromatic hydrocarbons like benzene and dichloromethane, and as a support for catalysts in biodiesel production. Its efficacy stems from its porous structure, high surface area, and surface functional groups that facilitate interactions with target substances. CSAC has also been investigated as an aggregate in eco-friendly concrete.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Coconut shell activated carbon.